All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-21593270
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 21593270 A7168G
LCR
Uterine Cervical Neoplasms
G
L
View
2 21593270 G7521A
LCR
Uterine Cervical Neoplasms
G
L
View
3 21593270 A5883C
L1
L1
Uterine Cervical Neoplasms
G
L
View
4 21593270 A6164G
L1
L1
Uterine Cervical Neoplasms
G
L
View
5 21593270 A6180C
L1
L1
Uterine Cervical Neoplasms
G
L
View
6 21593270 A7142C
L1
L1
Uterine Cervical Neoplasms
G
L
View
7 21593270 A7175C
L1
L1
Uterine Cervical Neoplasms
G
L
View
8 21593270 A7287C
L1
L1
Uterine Cervical Neoplasms
G
L
View
9 21593270 A7289C
L1
L1
Uterine Cervical Neoplasms
G
L
View
10 21593270 A7730C
L1
L1
Uterine Cervical Neoplasms
G
L
View
11 21593270 C24T
L1
L1
Uterine Cervical Neoplasms
G
L
View
12 21593270 C6826T
L1
L1
Uterine Cervical Neoplasms
G
L
View
13 21593270 C6938G
L1
L1
Uterine Cervical Neoplasms
G
L
View
14 21593270 C7270T
L1
L1
Uterine Cervical Neoplasms
G
L
View
15 21593270 G6085A
L1
L1
Uterine Cervical Neoplasms
G
L
View
16 21593270 G7060A
L1
L1
Uterine Cervical Neoplasms
G
L
View
17 21593270 G7842A
L1
L1
Uterine Cervical Neoplasms
G
L
View
18 21593270 K108T
L1
L1
Uterine Cervical Neoplasms
G
L
View
19 21593270 K528Q
L1
L1
Uterine Cervical Neoplasms
G
L
View
20 21593270 M175I
L1
L1
Uterine Cervical Neoplasms
G
L
View
21 21593270 N207T
L1
L1
Uterine Cervical Neoplasms
G
L
View
22 21593270 P460A
L1
L1
Uterine Cervical Neoplasms
G
L
View
23 21593270 T202A
L1
L1
Uterine Cervical Neoplasms
G
L
View
24 21593270 T7177C
L1
L1
Uterine Cervical Neoplasms
G
L
View
25 21593270 T7201C
L1
L1
Uterine Cervical Neoplasms
G
L
View
26 21593270 A645C
E7
E7
Uterine Cervical Neoplasms
G
L
View
27 21593270 A647G
E7
E7
Uterine Cervical Neoplasms
G
L
View
28 21593270 G666A
E7
E7
Uterine Cervical Neoplasms
G
L
View
29 21593270 L28F
E7
E7
Uterine Cervical Neoplasms
G
L
View
30 21593270 N29S
E7
E7
Uterine Cervical Neoplasms
G
L
View
31 21593270 T760C
E7
E7
Uterine Cervical Neoplasms
G
L
View
32 21593270 T843C
E7
E7
Uterine Cervical Neoplasms
G
L
View
33 21593270 T846C
E7
E7
Uterine Cervical Neoplasms
G
L
View
34 21593270 A131C
E6
E6
Uterine Cervical Neoplasms
G
L
View
35 21593270 A276G
E6
E6
Uterine Cervical Neoplasms
G
L
View
36 21593270 A442C
E6
E6
Uterine Cervical Neoplasms
G
L
View
37 21593270 C80G
E6
E6
Uterine Cervical Neoplasms
G
L
View
38 21593270 D25E
E6
E6
Uterine Cervical Neoplasms
G
L
View
39 21593270 D25N
E6
E6
Uterine Cervical Neoplasms
G
L
View
40 21593270 E113D
E6
E6
Uterine Cervical Neoplasms
G
L
View
41 21593270 G176A
E6
E6
Uterine Cervical Neoplasms
G
L
View
42 21593270 G94A
E6
E6
Uterine Cervical Neoplasms
G
L
View
43 21593270 L83V
E6
E6
Uterine Cervical Neoplasms
G
L
View
44 21593270 N58S
E6
E6
Uterine Cervical Neoplasms
G
L
View
45 21593270 T178A
E6
E6
Uterine Cervical Neoplasms
G
L
View
46 21593270 T178G
E6
E6
Uterine Cervical Neoplasms
G
L
View
47 21593270 T241G
E6
E6
Uterine Cervical Neoplasms
G
L
View
48 21593270 T341G
E6
E6
Uterine Cervical Neoplasms
G
L
View
49 21593270 T350G
E6
E6
Uterine Cervical Neoplasms
G
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.